AI agents in Biological Products, (No Diagnostic Substances)
5 companies in SIC 2836 (Biological Products, (No Diagnostic Substances)) have AI-agent language in SEC filings since 2025-01-01; 3 have at least one model-judged first-party deployment.
| Company | Stage | Functions | Mkt cap | Filings | Latest |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC.RXRX | Scaling | Healthcare & clinical, HR & recruiting, IT & security ops, Software development | $1.9B | 6 | 2026-10-15 |
| Iambic Therapeutics, Inc. | Deployed | Healthcare & clinical | — | 2 | 2026-10-08 |
| AMGEN INCAMGN | Deployed | Healthcare & clinical, IT & security ops, Operations & supply chain, Sales & marketing | $235.1B | 3 | 2026-08-05 |
| EXELIXIS, INC.EXEL | Risk factors only | — | $15.4B | 1 | 2026-02-10 |
| Cullinan Therapeutics, Inc.CGEM | Risk factors only | Healthcare & clinical, IT & security ops | $817M | 1 | 2026-03-10 |